ITK Inhibitor Induces Dose-Dependent Th1 Skewing in Normal T Cells and Is Active in Refractory T Cell Lymphomas Song, Y., Ding, N., Yoon, D., Reneau, J. C., Wilcox, R. A., Kim, W., Kim, Y. H., Khodadoust, M. S., Feldman, T. A., Yannakou, C. K., Giri, P., Brammer, J. E., Hsu, L., Yuan, H., Verner, E., Mahabhashyam, S., Miller, R. A. AMER SOC HEMATOLOGY. 2022: 8857-8859

View details for DOI 10.1182/blood-2022-159177

View details for Web of Science ID 000893230301424